SureTrader SureTrader
Home > Boards > US Listed > Biotechs > NorthWest Biotherapeutics (NWBO)

Here is the link to Germany DCVax Clinical

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
john1045 Member Profile
 
Followed By 31
Posts 2,274
Boards Moderated 0
Alias Born 06/09/11
160x600 placeholder
NW Bio Announces Decision to Voluntarily Withdraw from Nasdaq Listing and Begin Trading on OTC Market "PR Newswire (US)" - 12/7/2016 8:00:00 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 12/1/2016 4:20:39 PM
RT Minerals Corp. (TSX.V: RTM), High Grade Gold Norwalk Property, Drill Plan Ballard Lake Property "InvestorsHub NewsWire" - 11/22/2016 8:05:00 AM
NW Bio Announces Phase II Clinical Trial Program Combining DCVax®-L and Pembrolizumab (Keytruda®) for Colorectal Cancer "PR Newswire (US)" - 11/17/2016 8:15:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/14/2016 5:07:23 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/10/2016 4:36:27 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 11/9/2016 4:52:01 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/27/2016 10:35:46 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 10/25/2016 5:09:36 PM
NW BIO Announces Registered Direct Offering "PR Newswire (US)" - 10/21/2016 9:45:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/19/2016 5:30:05 PM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 10/19/2016 6:01:50 AM
Securities Registration Statement (simplified Form) (s-3/a) "Edgar (US Regulatory)" - 10/14/2016 3:31:50 PM
Securities Registration Statement (simplified Form) (s-3/a) "Edgar (US Regulatory)" - 10/7/2016 6:03:36 AM
Could these companies be setting up for a rebound? "InvestorsHub NewsWire" - 10/6/2016 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/4/2016 5:15:19 PM
Justin Timberlake’s Aftermaster, Inc. (OTCQB: AFTM) Begins Production - Partners with ON Semiconductor (NADAQ: ON) "InvestorsHub NewsWire" - 10/4/2016 7:00:00 AM
Securities Registration Statement (simplified Form) (s-3/a) "Edgar (US Regulatory)" - 10/3/2016 6:08:53 AM
NW Bio Presents Further DCVax®-Direct Phase I Trial Information On Individual Patient Survival At NY Cancer Immunotherapy Co... "PR Newswire (US)" - 9/29/2016 9:26:00 AM
Natural Gas Demand and Hydrogen Production Technologies May Be Bright Spot for Energy Sector Stocks as Sales Increase "InvestorsHub NewsWire" - 9/28/2016 8:45:00 AM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 9/23/2016 5:21:50 PM
NW Bio Presents Updated Data From DCVax®-Direct Phase I Trial At 5th Annual SMi Cancer Vaccines Conference in London "PR Newswire (US)" - 9/21/2016 1:52:00 PM
Friendable Inc. (OTC Pink: FDBL), Sony Corp’s (NYSE: SNE) Epic Records - Meghan Trainor Concert Ticket Giveaway a Success! "InvestorsHub NewsWire" - 9/20/2016 7:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 9/19/2016 2:48:13 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 9/19/2016 2:45:38 PM
john1045   Monday, 12/24/12 04:47:16 PM
Re: None
Post # of 87502 
Here is the link to Germany DCVax Clinical trials with an area I pasted from long report so they obviously are recruiting over there as of now....

http://translate.google.com/translate?hl=en&sl=de&u=http://www.uniklinik-duesseldorf.de/fileadmin/Datenpool/einrichtungen/universitaetstumorzentrum_id505/neu2012/Dateien/Klinische_Studien_UTZ_Duesseldorf.pdf&prev=/search%3Fq%3Ddcvax%26start%3D50%26hl%3Den%26sa%3DN%26tbo%3Dd%26biw%3D1366%26bih%3D586%26tbs%3Dqdr:w&sa=X&ei=I8nYULiqM7GH0QGx6oDACg&ved=0CGwQ7gEwCTgy

Page 11 of 23

Clinical trials in brain tumors


IND No. 10206

Glioblastoma (brain cancer)

Phase II clinical trial to evaluate DCVax-Brain, autologous dendritic cells pulsed with tumor lysate, for treatment

of glioblastoma multiforme.



A Phase II Clinical Trial Evaluating DCVax-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate for the Treatment of Glioblastoma

Multiforme

Your contact:

Prof. Dr. Michael Sabel

Michael.Sabel @ med.uni-duesseldorf.de



Page 12


Current clinical studies at University Cancer Center UTZ

University Cancer Center UTZ

Info Phone: 0211-8108200

at the University Hospital Dusseldorf

www.uniklinik-duesseldorf.de/utz

Stand: 01/2013

Page 12 of 23

Clinical trials in brain tumors

Fraunhofer Institute

Glioblastoma (brain cancer)

Phase II clinical study evaluating DCVax ®-L Brain autologous dendritic cells loaded with tumor lysate antigen for

Treatment of glioblastoma multiforme (GBM)

Clinical phase II trial to evaluate DCVax ®-L Brain autologous dendritic cells loaded with tumor lysate antigen for treatment of glioblastoma

multiforme (GBM)

Your contact:

Infoline

Tel: 0211-8108200

uta@med.uni-duesseldorf.de


SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist